Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Roche’s ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Histologie de la sclerose en plaques
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
Support MSDF
MS Patient, Ph.D.: Setting the Right Expectations for Recovery
Foreseeing the Future?
MS Research Roundup: January 9, 2014
MS Research Roundup: November 21, 2014
The origin and application of experimental autoimmune encephalomyelitis.
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
iConquerMS™ Advances Patient-Driven Multiple Sclerosis Research
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica: Multicenter Study of Treatment Efficacy.
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.
National MS Society: Pilot Research Grants
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
Low testosterone is associated with disability in men with multiple sclerosis.
ISN-APSN Biennial Meeting

Pages